The latest leg of the decline traces back to a detailed report from Kotak Institutional Equities last week, which highlighted inconsistencies across the company’s filings. The brokerage pointed to missing inter-company transactions, including purchases of Rs 180 crore, payables of Rs 320 crore and receivables of Rs 190 crore, alongside questions around the treatment of goodwill, borrowing costs and a rising contingent-liability profile.
Kaynes described the omissions as “inadvertent” and said the discrepancies had been corrected in its consolidated financial statements. But the market’s reaction was swift and broad, with institutional investors cutting exposure and technical levels breaking sharply on heavy volumes.
Against this backdrop, Tuesday’s sharp rebound was widely interpreted as short-covering rather than renewed conviction.
Sentiment weakened further on Wednesday after a fresh note from Kotak Securities maintained its cautious stance and slashed the firm’s target price once again. The brokerage said it maintains its ‘reduce’ rating on the stock but slashed its target price to Rs 4,150 from Rs 6,180.
Certain aspects with respect to intangible accounting and elevated working capital still remain unclear, the brokerage noted, adding that its sees FY2026 guidance at risk and believes generation of positive OCF in FY26, improvement in internal controls and timely execution of PCB and OSAT expansion will be crucial.
The reiteration of unresolved accounting and cash-flow concerns reinforced investor unease, contributing to the renewed slide.
‘Risk–reward has improved, but volatility stays elevated’
Some analysts, however, say the correction has reset valuation expectations. Harshal Dasani, Business Head at INVasset PMS, said the “risk–reward has certainly improved in the near term, but volatility will remain elevated until delivery data stabilises and institutional flows turn supportive.”
Dasani noted that “pockets of over-ownership and stretched valuations had built up through 2024–25,” making the stock vulnerable to adverse news.
While Tuesday’s bounce offered temporary relief, Dasani said “the rebound suggests short-covering and value buying at lower bands, yet sustainable recovery will depend on how quickly fundamentals re-anchor.”
Technical structure weak despite oversold signals
Dasani warned that the technical picture remains fragile. “Technically, the stock is attempting to stabilise after a steep drawdown, but the structure remains fragile,” he said. The decline has “sliced through key short-term averages, creating overhead supply zones that will act as resistance until volumes confirm strength.”
Momentum indicators have slipped into oversold territory, but Dasani cautioned that “oversold is not the same as trend reversal — confirmation typically comes only when prices reclaim short- and medium-term moving averages with supportive breadth.”
“MACD remains in a negative crossover,” he said, signalling persistent selling pressure.
Balance-sheet discipline now a critical watchpoint
On fundamentals, Dasani said the focus must shift to capital efficiency and governance consistency. “Working-capital stretch in the EMS sector isn’t uncommon… however, sustained elongation does compress cash flows and elevates dependence on short-term borrowings,” he noted.
Dasani said that “related-party disclosures and rising contingent liabilities merit close monitoring… because they shape investor perception of governance and balance-sheet quality.” He said valuation stability will be driven by clarity on receivable cycles and liability management.
Growth pivot underway as smart-meter cycle tapers
With the smart-meter boom cooling, investors are assessing Kaynes’ next growth levers. Dasani said “the next leg of growth in the EMS ecosystem will depend on diversification — especially industrial, automotive electronics, and emerging high-reliability segments.”
While space-tech presents long-cycle optionality, he said “it will scale meaningfully only over a multi-year horizon, not in the next quarter or two.”
The stock’s renewed slide reflects a market recalibrating rapidly to governance concerns and balance-sheet questions. While the sharp correction has improved near-term valuations, the technical structure remains weak, disclosures are under heightened scrutiny and institutional participation remains tentative.
For investors, Kaynes now sits in a high-volatility zone where caution carries more weight than conviction. A durable recovery will require clearer signals, on cash flows, internal controls, order momentum and the company’s ability to reclaim technical thresholds.
Until then, the debate over whether to buy, sell or hold remains tightly tied to risk appetite rather than visibility.
Also read | Kaynes Technology shares rebound 14% after crashing 30% in 4 days. Should you get in or get out now?
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)